News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Invitae Offers BRCA1/BRCA2 Testing, Providing Clinicians With A Reliable, Fast, Affordable Option For Patients



12/11/2013 8:58:08 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

SAN ANTONIO--(BUSINESS WIRE)--Invitae Corporation, a genetic diagnostics company, today announced at the 2013 San Antonio Breast Cancer Symposium that it now offers BRCA1 and BRCA2 testing globally, providing clinicians with a reliable, fast and affordable option for their cancer patients. Available with a turnaround time of just two weeks, this test includes full gene sequencing for both BRCA1 and BRCA2, as well as deletion/duplication analysis. The test is globally available and is priced at $1,500 in the United States.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
Invitae
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES